Following an inconclusive mammogram and ultrasound, clinicians can use SenoBright HD, a next-generation Contrast Enhanced Spectral Mammography (CESM) exam designed to aid health care providers in breast cancer diagnosis by delivering clear images for a confident and fast patient diagnosis and overall improved patient experience. It is a less expensive alternative diagnostic exam in comparison to breast MRI and is now available on the Senographe Pristina. The patient receives an iodine contrast agent to acquire a standard four-view mammogram. Using dual energy to reduce background signal, the contrast agent used with SenoBright HD highlights areas of unusual blood flow to help localize a known or suspected lesion. The contrast-enhanced mammogram provides high specificity, delivers clear image quality and reduces acquisition time by 40 percent in women with large breasts compared to GE Healthcare’s first generation CESM technology, helping to reduce the risk of patient movement during acquisition*. The entire exam typically takes less than seven minutes and the images are available immediately for a radiologist to review**.
* Data on file at GE Healthcare
** Daniaux et al. Arch Gynecol Obstet, 2015
